Results 41 to 50 of about 411,751 (361)

Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting

Arthritis Care &Research, EarlyView.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr, Michael D. George, Vatinee Y. Bunya, Nora Sandorfi, Mina Massaro‐Giordano, Frederick B. Vivino   +5 more
wiley   +1 more source

Feasibility and Utility of a Pilot Peer Education Program to Improve Patient Engagement in Lupus Clinical Trials: Implementation and Evaluation in a Multisite Model Within a Lupus Clinical Trials Network

ACR Open Rheumatology, 2023
Objective To assess outcomes related to Lupus Therapeutics’ Patient Advocates for Lupus Studies (LT‐PALS), a peer‐to‐peer lupus clinical trial (LCT) education program designed to improve representation of diverse groups in LCTs.
Saira Z. Sheikh, Caroline Donovan, Carla Menezes, Albert T. Roy, Andrew Simkus, Diane Gross, Anca Askanase, Rosalind Ramsey‐Goldman, Vikas Majithia, Nicole Wanty, Annie McNeill, Kristen Holtz, S. Sam Lim   +12 more
doaj   +1 more source

The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and lupus nephritis

, 2014
Objective: The expression of connective tissue growth factor mRNA in human kidneys may serve as an early marker for lupus nephritis progression. Therefore, we speculated that connective tissue growth factor may be involved in the pathogenesis of systemic
Wang, F-M, Zhao, M-H, Liu, G., Yu, F., Tan, Y.   +4 more
core   +1 more source

Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus

, 2020
Objective Persistent positivity for lupus anticoagulant has been associated with an increased risk of thrombosis among patients with SLE. Persistent positivity is often defined as having two positive assessments separated by more than 90 days.
Avci, Mertcan, Magder, Laurence S., Petri, Michelle A.   +2 more
core   +1 more source

Cognitive Behavioral Therapy for Youth With Childhood‐Onset Lupus: A Randomized Clinical Trial

Arthritis Care &Research, EarlyView.
Objective Our objective was to determine the feasibility and acceptability of the Treatment and Education Approach for Childhood‐Onset Lupus (TEACH), a six‐session cognitive behavioral intervention addressing depressive, fatigue, and pain symptoms, delivered remotely to individual youth with lupus by a trained interventionist.
Natoshia R. Cunningham, Thea Senger‐Carpenter, Jocelyn Zuckerman, Michelle Adler, Mallet R. Reid, Ashley Danguecan, Luana Flores Pereira, Sarah I. Mossad, Samantha L. Ely, Khalid Abulaban, Elizabeth A. Kessler, Natalie Rosenwasser, Tamar B. Rubinstein, Ekemini A. Ogbu, Emily A. Smitherman, Alaina Miller, Taylor Abounader, Elizabeth Ross, Livie Timmerman, Dhriti Sharma, Jennifer N. Stinson, Stacy Allen, Kabita Nanda, Tala El Tal, Deborah M. Levy, Linda T. Hiraki, Hermine I. Brunner, Mathew Reeves, Steven J. Pierce, Andrea Knight   +29 more
wiley   +1 more source

Acute Acalculous Cholecystitis In Juvenile Systemic Lupus Erythematosus

, 2015
Small- and medium-vessel vasculitis is a common manifestation in systemic lupus erythematosus (SLE) and may occur in any organ. However, acute acalculous cholecystitis is a rare abdominal manifestation in SLE, especially in children.
Appenzeller S., Mendonca J.A., Marques-Neto J.F., Prando P.   +3 more
core   +2 more sources

Belimumab : a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis [PDF]

, 2013
Objectives: To undertake a systematic review and meta-analysis to investigate clinical effectiveness of belimumab for patients with systemic lupus erythematosus (SLE) and antinuclear and/or anti-double-stranded DNA (dsDNA) autoantibodies.
Hartley, Louise, Court, Rachel, Cummins, E., Court, Rachel; id_orcid, Grove, Amy, Mohiuddin, Syed, Connock, Martin, Grove, Amy L., Sutcliffe, Paul, Kandala, Ngianga-Bakwin, Court, Rachel A., Kandala, Ngianga Bakwin, Cummins, Ewen, Connock, M., Sutcliffe, P. (Paul), Gordon, Caroline, Grove, Amy; id_orcid, Clarke, Aileen   +17 more
core   +1 more source

Association Between Symptomatic Knee Osteoarthritis and Target Glycemic Control in Individuals With Type 2 Diabetes

Arthritis Care &Research, EarlyView.
Objective Knee osteoarthritis (OA) commonly affects individuals with type 2 diabetes (T2DM) and is associated with increased risk of diabetes‐related complications. To better understand potential mechanisms, we examined the association between symptomatic knee OA and glycemic control in individuals with T2DM.
Lauren K. King, Alanna Weisman, Baiju R. Shah, Robert Goldberg, Amish Parikh, Ian Stanaitis, Vivian Hung, Rosane Nisenbaum, Abdalmohsen Almodahka, Lorraine Lipscombe, Gillian A. Hawker   +10 more
wiley   +1 more source

Are Tattoos Safe in Patients With Systemic Lupus Erythematosus? Results From a Single-Center Study

Dermatology Practical & Conceptual
Introduction: Systemic Lupus Erythematosus is a pleiotropic autoimmune disease with common skin involvement. To date, only one study has investigated tattoos safety in SLE patients.
Francesco Natalucci, Fulvia Ceccarelli, Licia Picciariello, Giulio Olivieri, Claudia Ciancarella, Cristiano Alessandri, Fabrizio Conti   +6 more
doaj   +1 more source

Childhood-onset bullous systemic lupus erythematosus

, 2014
Bullous systemic lupus erythematosus has rarely been described in pediatric lupus population and the real prevalence of childhood-onset bullous systemic lupus erythematosus has not been reported.
Campos, L. M. A., Romiti, R., Aikawa, N. E., Lourenco, D. M. R., Gomes, R. Cunha, Silva, C. A.   +5 more
core   +1 more source